{"denoms":[{"counts":[{"groupId":"BG000","value":"37"},{"groupId":"BG001","value":"224"},{"groupId":"BG002","value":"220"},{"groupId":"BG003","value":"221"},{"groupId":"BG004","value":"702"}],"units":"Participants"}],"groups":[{"description":"Encorafenib + binimetinib + cetuximab. Encorafenib: Orally, once daily. Binimetinib: Orally, twice daily. Cetuximab: Standard of care.","id":"BG000","title":"Combined Safety Lead-in (CSLI)"},{"description":"Encorafenib + binimetinib + cetuximab. Encorafenib: Orally, once daily. Binimetinib: Orally, twice daily. Cetuximab: Standard of care.","id":"BG001","title":"Phase 3: Triplet Arm"},{"description":"Encorafenib + cetuximab. Encorafenib: Orally, once daily. Cetuximab: Standard of care.","id":"BG002","title":"Phase 3: Doublet Arm"},{"description":"Investigator's choice of either irinotecan/cetuximab or FOLFIRI/cetuximab. Cetuximab: Standard of care. Irinotecan: Standard of care. Folinic Acid: Standard of care. 5-Fluorouracil: Standard of care. Following protocol amendment, eligible participants could crossover to receive either triplet or doublet regimen.","id":"BG003","title":"Phase 3: Control Arm"},{"description":"Total of all reporting groups","id":"BG004","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"}],"title":"<=18 years"},{"measurements":[{"groupId":"BG000","value":"23"},{"groupId":"BG001","value":"141"},{"groupId":"BG002","value":"137"},{"groupId":"BG003","value":"149"},{"groupId":"BG004","value":"450"}],"title":"Between 18 and 65 years"},{"measurements":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"83"},{"groupId":"BG002","value":"83"},{"groupId":"BG003","value":"72"},{"groupId":"BG004","value":"252"}],"title":">=65 years"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Categorical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"10.34","value":"58.3"},{"groupId":"BG001","spread":"11.65","value":"59.5"},{"groupId":"BG002","spread":"11.65","value":"60.2"},{"groupId":"BG003","spread":"12.07","value":"58.4"},{"groupId":"BG004","spread":"11.80","value":"59.3"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"22"},{"groupId":"BG001","value":"119"},{"groupId":"BG002","value":"106"},{"groupId":"BG003","value":"127"},{"groupId":"BG004","value":"374"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"15"},{"groupId":"BG001","value":"105"},{"groupId":"BG002","value":"114"},{"groupId":"BG003","value":"94"},{"groupId":"BG004","value":"328"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"14"},{"groupId":"BG002","value":"13"},{"groupId":"BG003","value":"6"},{"groupId":"BG004","value":"33"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"37"},{"groupId":"BG001","value":"203"},{"groupId":"BG002","value":"195"},{"groupId":"BG003","value":"202"},{"groupId":"BG004","value":"637"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"12"},{"groupId":"BG003","value":"13"},{"groupId":"BG004","value":"32"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"1"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"20"},{"groupId":"BG002","value":"25"},{"groupId":"BG003","value":"39"},{"groupId":"BG004","value":"91"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"3"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"29"},{"groupId":"BG001","value":"195"},{"groupId":"BG002","value":"183"},{"groupId":"BG003","value":"172"},{"groupId":"BG004","value":"579"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"11"},{"groupId":"BG003","value":"10"},{"groupId":"BG004","value":"28"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"30"},{"groupId":"BG002","value":"28"},{"groupId":"BG003","value":"29"},{"groupId":"BG004","value":"92"}],"title":"North America"},{"measurements":[{"groupId":"BG000","value":"25"},{"groupId":"BG001","value":"150"},{"groupId":"BG002","value":"145"},{"groupId":"BG003","value":"125"},{"groupId":"BG004","value":"445"}],"title":"Europe"},{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"47"},{"groupId":"BG003","value":"67"},{"groupId":"BG004","value":"165"}],"title":"Rest of World"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Region","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"22"},{"groupId":"BG001","value":"116"},{"groupId":"BG002","value":"112"},{"groupId":"BG003","value":"108"},{"groupId":"BG004","value":"358"}],"title":"0-Fully active"},{"measurements":[{"groupId":"BG000","value":"15"},{"groupId":"BG001","value":"108"},{"groupId":"BG002","value":"104"},{"groupId":"BG003","value":"113"},{"groupId":"BG004","value":"340"}],"title":"1-Restircted in physically strenuous activity"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"4"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"4"}],"title":"2-Ambulatory and capable of all self-care"}]}],"description":"ECOG PS was used to assess the physical health of participants, and ranges from 0 to 5 where 0: fully active, 1: restricted in physically strenuous activity, 2: ambulatory and capable of self-care but unable to work, 3: capable only of limited self-care , 4: completely disabled; cannot carry on any self-care; totally confined to bed or chair, 5: dead.","paramType":"COUNT_OF_PARTICIPANTS","title":"Eastern Cooperative Oncology Group Performance Status (ECOG PS) at Baseline","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"79"},{"groupId":"BG002","value":"83"},{"groupId":"BG003","value":"68"},{"groupId":"BG004","value":"241"}],"title":"Left Colon"},{"measurements":[{"groupId":"BG000","value":"23"},{"groupId":"BG001","value":"126"},{"groupId":"BG002","value":"110"},{"groupId":"BG003","value":"119"},{"groupId":"BG004","value":"378"}],"title":"Right Colon"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"11"},{"groupId":"BG003","value":"22"},{"groupId":"BG004","value":"41"}],"title":"Left and Right Colon"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"11"},{"groupId":"BG002","value":"16"},{"groupId":"BG003","value":"12"},{"groupId":"BG004","value":"42"}],"title":"Unknown"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Number of Participants According to Primary Tumor Location","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"20"},{"groupId":"BG001","value":"133"},{"groupId":"BG002","value":"123"},{"groupId":"BG003","value":"122"},{"groupId":"BG004","value":"398"}],"title":"Completely Resected"},{"measurements":[{"groupId":"BG000","value":"17"},{"groupId":"BG001","value":"91"},{"groupId":"BG002","value":"97"},{"groupId":"BG003","value":"99"},{"groupId":"BG004","value":"304"}],"title":"Partially Resected/Unresected"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Number of Participants According to Removal of Primary Tumor","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"114"},{"groupId":"BG002","value":"117"},{"groupId":"BG003","value":"123"},{"groupId":"BG004","value":"370"}],"title":"<=2"},{"measurements":[{"groupId":"BG000","value":"21"},{"groupId":"BG001","value":"110"},{"groupId":"BG002","value":"103"},{"groupId":"BG003","value":"98"},{"groupId":"BG004","value":"332"}],"title":"3+"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Number of Participants According to Number of Organs Involved","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"24"},{"groupId":"BG001","value":"145"},{"groupId":"BG002","value":"134"},{"groupId":"BG003","value":"128"},{"groupId":"BG004","value":"431"}]}],"title":"Liver"},{"categories":[{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"86"},{"groupId":"BG002","value":"83"},{"groupId":"BG003","value":"86"},{"groupId":"BG004","value":"265"}]}],"title":"Lung"},{"categories":[{"measurements":[{"groupId":"BG000","value":"17"},{"groupId":"BG001","value":"86"},{"groupId":"BG002","value":"82"},{"groupId":"BG003","value":"88"},{"groupId":"BG004","value":"273"}]}],"title":"Lymph Node"},{"categories":[{"measurements":[{"groupId":"BG000","value":"17"},{"groupId":"BG001","value":"77"},{"groupId":"BG002","value":"97"},{"groupId":"BG003","value":"93"},{"groupId":"BG004","value":"284"}]}],"title":"Peritoneum/Omentum"}],"description":"One participant may have more than one site of metastases.","paramType":"NUMBER","title":"Sites of Metastases","unitOfMeasure":"Sites"}],"populationDescription":"The baseline analysis population consists of the Full Analysis Set (FAS). For participants in the CSLI, the FAS includes all participants who received at least 1 dose of study drug and had at least 1 post treatment assessment, which may include death. For the randomized Phase 3 portion of the study, the FAS consists of all randomized participants."}